POTOMAC, MD / ACCESSWIRE / November 6, 2024 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is pleased to announce the publication of a new interview with CEO Ram Mukunda, now ...

FORT LAUDERDALE, FL / ACCESSWIRE / November 6, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...

DALLAS, TX / ACCESSWIRE / November 6, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the completion of a merger agreement with Sanctum Therapeutics Corporation to acquire Sanctum ...

Heidelberg Pharma AG (FSE: HPHA), a clinical-stage developer of innovative Antibody Drug Conjugates (ADCs), today announces that new clinical data on its lead Amanitin-based ADC candidate, HDP-101, ...

Today, BC Platforms, a global leader in real-world data, healthcare data management, and analytics, announces the launch of its market-leading EHDS-Ready Trusted Research Environment (TRE)*. The ...

Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a ...

Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), and Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) Fluor & Energy Materials (Koura), a global ...

Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief ...

The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children as young as one year of age. Specifically, the approval covers children aged one to ...

The global women’s health applications market is on the brink of a remarkable transformation, with projections indicating an extraordinary surge from USD 3.4 billion in 2022 to an astonishing USD 24 ...

The global molecular spectroscopy market is poised for substantial growth, with projections indicating it will reach a valuation of USD 12.87 billion by 2033, up from USD 6.42 billion in 2023, at a ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...